Certain information identified with [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2021 • Novavax Inc • Biological products, (no disgnostic substances) • Maryland
This Employment Agreement (this “Agreement”) is dated as of October 30, 2020, between Novavax, Inc., (“Novavax” or the “Company”) a Delaware corporation having its principal office at 21 Firstfield Road, Gaithersburg, MD 20878, and Gregory Covino, an individual having a current mailing address of [***] (“Executive”).
92634891_7 The total amount of funding currently available for payment and allotted to this Project Agreement is $1,600,339,523. The amount specified, or as such amount may be increased from time to time, shall apply irrespective of any other...Novavax Inc • March 1st, 2021 • Biological products, (no disgnostic substances)
EXECUTION VERSION -2- 70472309_1 2. Sale of Product. 2.1. Generally. During the Term, Customer hereby commits to purchase from Novavax the Vaccine, which will be supplied in [***] (the “Product”), in an amount equal to the aggregate quantity of...Advanced Purchase Agreement • March 1st, 2021 • Novavax Inc • Biological products, (no disgnostic substances)
2- 91837512_5 deployment and administration, and that Customer will be solely responsible for the use, deployment and administration of Product to individuals in the Territory. The terms and conditions of this Agreement, including with respect to...Advanced Purchase Agreement • March 1st, 2021 • Novavax Inc • Biological products, (no disgnostic substances)
CONTENTS Clause Page 1. Definitions ........................................... .............................................................................. 3 2. Governance ..................................................................Novavax Inc • March 1st, 2021 • Biological products, (no disgnostic substances)
